Show simple item record

dc.contributor.authorLeija‐Salazar, M
dc.contributor.authorSedlazeck, FJ
dc.contributor.authorToffoli, M
dc.contributor.authorMullin, Stephen
dc.contributor.authorMokretar, K
dc.contributor.authorAthanasopoulou, M
dc.contributor.authorDonald, A
dc.contributor.authorSharma, R
dc.contributor.authorHughes, D
dc.contributor.authorSchapira, AHV
dc.contributor.authorProukakis, C
dc.date.accessioned2019-05-01T19:00:36Z
dc.date.issued2019-03
dc.identifier.issn2324-9269
dc.identifier.issn2324-9269
dc.identifier.otherARTN e564
dc.identifier.urihttp://hdl.handle.net/10026.1/13761
dc.description.abstract

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Mutations in <jats:italic>GBA</jats:italic> cause Gaucher disease when biallelic and are strong risk factors for Parkinson's disease when heterozygous. <jats:italic>GBA</jats:italic> analysis is complicated by the nearby pseudogene. We aimed to design and validate a method for sequencing <jats:italic>GBA </jats:italic>using long reads.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We sequenced <jats:italic>GBA</jats:italic> on the Oxford Nanopore MinION as an 8.9 kb amplicon from 102 individuals, including patients with Parkinson's and Gaucher diseases. We used NanoOK for quality metrics, NGMLR to align data (after comparing with GraphMap), Nanopolish and Sniffles to call variants, and WhatsHap for phasing.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We detected all known missense mutations in these samples, including the common p.N409S (N370S) and p.L483P (L444P) in multiple samples, and nine rarer ones, as well as a splicing and a truncating mutation, and intronic SNPs. We demonstrated the ability to phase mutations, confirm compound heterozygosity, and assign haplotypes. We also detected two known risk variants in some Parkinson's patients. Rare false positives were easily identified and filtered, with the Nanopolish quality score adjusted for the number of reads a very robust discriminator. In two individuals carrying a recombinant allele, we were able to detect and fully define it in one carrier, where it included a 55‐base pair deletion, but not in another one, suggesting a limitation of the PCR enrichment method. Missense mutations were detected at the correct zygosity, except for the case where the RecNciI one was missed.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The Oxford Nanopore MinION can detect missense mutations and an exonic deletion in this difficult gene, with the added advantages of phasing and intronic analysis. It can be used as an efficient research tool, but additional work is required to exclude all recombinants.</jats:p></jats:sec>

dc.format.extente564-e564
dc.format.mediumPrint-Electronic
dc.languageen
dc.language.isoen
dc.publisherWiley Open Access
dc.subjectGaucher disease
dc.subjectGBA
dc.subjectlong-read sequencing
dc.subjectmutation detection
dc.subjectmutation phasing
dc.subjectOxford Nanopore MinION
dc.subjectParkinson's disease
dc.titleEvaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION
dc.typejournal-article
dc.typeEvaluation Study
dc.typeJournal Article
dc.typeResearch Support, N.I.H., Extramural
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461447100008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue3
plymouth.volume7
plymouth.publication-statusPublished
plymouth.journalMolecular Genetics and Genomic Medicine
dc.identifier.doi10.1002/mgg3.564
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/FoH - Applied Parkinson's Research
plymouth.organisational-group/Plymouth/Research Groups/FoH - Community and Primary Care
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Researchers in ResearchFish submission
dc.publisher.placeUnited States
dcterms.dateAccepted2018-12-13
dc.rights.embargodate2019-11-23
dc.identifier.eissn2324-9269
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1002/mgg3.564
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2019-03
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV